Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY:DVA)

118.20 -1.84 (-1.54%)
Streaming Delayed Price Updated: 2:28 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
3 Medical Device Stocks to Buy for Cutting-Edge Innovation and Growth ↗
Medical device stocks are set to rise with an aging population and continued improvements in technology. Here are 3 stocks to watch. 
Via InvestorPlace
News headline image
You Won't Believe How Much More Warren Buffett Has Made Than the Market Since 1965 ↗
The trick is waiting long enough to let the magic of compounding do its work. 
Via The Motley Fool
News headline image
DaVita (DVA) Q4 2022 Earnings Call Transcript ↗
DVA earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
The 7 Best Beaten-Down Warren Buffett Stocks to Buy ↗
Investors will want to take a close look at these beaten-down Warren Buffett stocks to buy for long-term appreciation. 
Via InvestorPlace
News headline image
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the  SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth, 
Via Benzinga
Here's How Much You Would Have Made Owning DaVita Stock In The Last 20 Years ↗
 
Via Benzinga
Here's How Much $1000 Invested In DaVita 20 Years Ago Would Be Worth Today ↗
 
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today ↗
 
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,500 Today ↗
 
Via Benzinga
News headline image
Sell These 3 Stocks and Kick These Overpaid CEOs Out of Your Portfolio ↗
Now is the time to cut your losses on some of your 2022 losers. Here are three stocks to sell whose CEOs didn’t earn their keep. 
Via InvestorPlace
News headline image
Siemens Healthineers, GE Healthcare Studying Potential Deals With Medtronic's Spun Off Units ↗
 
Via Benzinga
News headline image
Warren Buffett Now Owns 20% or More of These 5 Companies ↗
Which are these big Buffett bets are the best picks for investors? 
Via The Motley Fool
News headline image
$1000 Invested In DaVita 20 Years Ago Would Be Worth This Much Today ↗
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 3.82% on an annualized basis producing an average annual return of 11.29%. Currently, DaVita has a market capitalization of $6.29... 
Via Benzinga
News headline image
DaVita Earnings Perspective: Return On Capital Employed ↗
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) showed a loss in earnings since Q2, totaling $164.69 million. Sales, on the other hand, increased by 0.75% to $2.95 billion during Q3. 
Via Benzinga
News headline image
DaVita (DVA) Q3 2022 Earnings Call Transcript ↗
DVA earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
Around $134 Million Bet On This Stock Up 46% Year-To-Date? 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Tuesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 96 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Analyst Ratings for DaVita ↗
Over the past 3 months, 5 analysts have published their opinion on DaVita (NYSE:DVA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Chevron To Rally Around 21%? Here Are 5 Other Price Target Changes For Monday ↗
Raymond James raised Chevron Corporation (NYSE: CVX) price target from $188 to $215. Raymond James analyst Justin Jenkins maintained the stock with an Outperform rating. Chevron shares fell 1.1% to... 
Via Benzinga
News headline image
Weibo, XPeng, Li Auto And Other Big Losers From Friday ↗
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. 
Via Benzinga
News headline image
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2% ↗
U.S. stocks extended gains toward the end of trading, with the Nasdaq Composite surging more than 200 points on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today ↗
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 4.09% on an annualized basis producing an average annual return of 11.52%. Currently, DaVita has a market capitalization of $6.63... 
Via Benzinga
News headline image
Dow Jumps 600 Points; Crude Oil Down Over 1% ↗
U.S. stocks extended gains midway through trading, with the Dow Jones surging more than 600 points on Friday. 
Via Benzinga
News headline image
2 Market-Moving Stocks You Can't Afford to Ignore ↗
Friday's market action saw volatility both upward and downward. 
Via The Motley Fool
News headline image
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) surged 179% to $3.6301. 
Via Benzinga
News headline image
US Stocks Mostly Higher; Dow Surges 300 Points ↗
U.S. stocks traded mostly higher this morning, with the Dow Jones surging more than 300 points on Friday. 
Via Benzinga
News headline image
Dialysis Provider DaVita Slashes FY22 Earnings Outlook Citing Continued Pandemic Impact, Shares Fall ↗
 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.